以色列Adar Biotech  
Adar Biotech公司成立于2006年3月，是下一代医疗技术开发者。公司开发了加强药物释放的微型医疗设备和应用于国土安全/生物恐怖的医疗设备；公司还为研究机构提供产品和服务。Adar Biotech生产功能性树脂、重组蛋白，并且向客户提供免疫学和细胞培养方面的服务。
Adar Biotech公司的研究服务包括：多肽合成，单克隆和多克隆抗体的订制，生物测定服务（ELISA法、快速检测、荧光为基础兼容超导的化验），荧光基团及其他标记的蛋白交联，基因克隆及表达，蛋白纯化和折叠，整套研发项目服务。
热门产品
蛋白A微珠 蛋白G微珠 重组蛋白和抗体

Adar Biotech, incorporated in March 2006, is a developer of next-generation medical technology. The company develops a miniature medical device for enhancement of drug delivery and another medical device with Homeland Security/Bioterrorism application. The company also provides products and services to the research community. Adar Biotech manufactures functional resins and recombinant proteins and supplies customers with immunological and cell-culture services. 

Adar Biotech's Research services include: Custom peptide synthesis. Monoclonal and polyclonal antibodies development. Bioassay development services: ELISA, rapid tests, fluorescence-based and HTS compatible assays. Custom conjugations of fluorophores and other markers to proteins. Gene cloning and gene expression. Protein purification and folding. Turnkey R&D projects services.